Press releases & News

0
Rate this post
  • Jul 05, 2019Hansa Biopharma to Host Conference Call to Supply Second Quarter 2019 Service Update
  • Jun 07, 2019Plenary Presentation at the 2019 American Transplant Congress Shows Significant Reduction in Time on the Waiting List for Clients Treated with Imlifidase Contrasted to Matched Controls
  • May 22, 2019Regulatory press release: Notice from the Annual General Satisfying in Hansa Biopharma abdominal (publ).
  • Might 13, 2019Hansa Biopharma to join UBS Global Healthcare Seminar and also RBC Funding Markets Global Healthcare Meeting in New York City City.
  • Might 02, 2019Regulatory news release: Hansa Biopharma Introduces Future Presentations at the 2019 American Transplant Congress.
  • Apr 29, 2019Hansa Biopharma increases leadership team with specialized functions for Corporate Communications, Financier Relations and also Business Development.
  • Apr 29, 2019Regulatory press release: Hansa Biopharma Meantime Report January– March 2019.
  • Apr 23, 2019Hansa Biopharma to Host Teleconference to Supply First Quarter 2019 Service Update.
  • Apr 17, 2019Regulatory news release: Notice to Yearly General Fulfilling in Hansa Biopharma abdominal (publ).
  • Apr 15, 2019Regulatory press release: Hansa Biopharma Receives Values as well as Regulatory Clearance to Start Phase 2 Research Study of Imlifidase in Guillain Barré Disorder.
  • Apr 15, 2019Regulatory news release: Hansa Biopharma unloads its equity keeping in Genovis.
  • Apr 15, 2019Regulatory news release: Hansa Biopharma publishes the Annual Report for 2018.
  • Mar 26, 2019Regulatory news release: Hansa Biopharma Obtains Ethics and also Governing Clearance to Start Phase 2 Study of imlifidase in Severe Antibody Mediated Rejection in Kidney Hair Transplant.
  • Mar 21, 2019Regulatory news release: Hansa Biopharma Reveals Choice of NiceR Lead Prospect.
  • Mar 06, 2019Hansa Biopharma to Existing at the Cowen 39th Yearly Healthcare Conference.
  • Mar 01, 2019Regulatory press release: Hansa Biopharma Introduces European Medicines Agency Accepts Advertising And Marketing Authorization Application for IDEFIRIX ™ (imlifidase).
  • Feb 28, 2019Regulatory news release: Boost of variety of shares and votes in Hansa Biopharma abdominal muscle (publ).
  • Feb 08, 2019Regulatory news release: Hansa Biopharma Year-End Record 2018.
  • Feb 07, 2019Regulatory news release: Hansa Biopharma appoints Donato Spota as brand-new Chief Financial Officer.
  • Jan 31, 2019Hansa Medical to Host Conference Call to Offer Year-End Report 2018 Service Update.
  • Jan 31, 2019Regulatory news release: Increase of number of enact Hansa Medical abdominal muscle (publ).
  • Jan 18, 2019Hansa Medical Reveals Appointment of Anne Säfström Lanner as Vice President, Global Human Resources.
  • Jan 15, 2019Regulatory press release: Hansa Medical AB Provides Regulatory Update for Imlifidase in Kidney Transplantation.

LÄMNA ETT SVAR

Vänligen ange din kommentar!
Vänligen ange ditt namn här